ArticleBritish journal of cancer2010

Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies.

P Hamberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.